IMpower131: Final OS Results of Carboplatin plus Nab-Paclitaxel ± Atezolizumab in Advanced Squamous NSCLC

被引：17

作者：

Jotte, R. ^{[1
]}

Cappuzzo, F. ^{[2
]}

Vynnychenko, I. ^{[3
]}

Stroyakovskiy, D. ^{[4
]}

Rodriguez Abreu, D. ^{[5
]}

Hussein, M. ^{[6
]}

Soo, R. ^{[7
]}

Conter, H. ^{[8
]}

Kozuki, T. ^{[9
]}

Huang, K. ^{[10
]}

Graupner, V. ^{[11
]}

Sun, S. ^{[10
]}

Hoang, T. ^{[10
]}

Jessop, H. ^{[11
]}

Mccleland, M. ^{[10
]}

Ballinger, M. ^{[10
]}

Sandler, A. ^{[10
]}

Socinski, M. ^{[12
]}

机构：

[1] Rocky Mt Canc Ctr, Denver, CO USA

[2] Azienda Unita Sanit Locale Romagna, Ravenna, Italy

[3] Sumy State Univ, Sumy, Ukraine

[4] Moscow City Oncol Hosp, Moscow Healthcare Dept, Moscow, Russia

[5] Univ Las Palmas Gran Canaria, Complejo Hosp Univ Insular Materno Infantil Gran, Las Palmas Gran Canaria, Spain

[6] Florida Canc Specialists, Lady Lake, FL USA

[7] Natl Univ Singapore Hosp, Singapore, Singapore

[8] William Osler Hlth Syst, Brampton, ON, Canada

[9] Natl Hosp Org Shikoku Canc Ctr, Matsuyama, Ehime, Japan

[10] Genentech Inc, San Francisco, CA 94080 USA

[11] F Hoffmann La Roche, Basel, Switzerland

[12] Florida Hosp Canc Inst, Orlando, FL USA

来源：

关键词：

Atezolizumab; Chemotherapy; squamous NSCLC;

D O I：

10.1016/j.jtho.2019.08.484

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OA14.02

引用

页码：S243 / S244

页数：3